The robust association between Ang-2 and 30-day mortality in patients with early sepsis, which is enhanced among a subgroup of patients with early sepsis who also have ARDS, suggests a conserved pathobiology role among heterogeneous critically ill patients. This evidence concerns the gene ANGPT2 and Sepsis.